Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism

Abstract Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 2014-05, Vol.340 (1), p.198-207
Hauptverfasser: Kozina, Elena A, Khakimova, Gulnara R, Khaindrava, Vitaly G, Kucheryanu, Valeriayn G, Vorobyeva, Nadezhda E, Krasnov, Alexey N, Georgieva, Sophia G, Kerkerian-Le Goff, Lidiya, Ugrumov, Michael V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 207
container_issue 1
container_start_page 198
container_title Journal of the neurological sciences
container_volume 340
creator Kozina, Elena A
Khakimova, Gulnara R
Khaindrava, Vitaly G
Kucheryanu, Valeriayn G
Vorobyeva, Nadezhda E
Krasnov, Alexey N
Georgieva, Sophia G
Kerkerian-Le Goff, Lidiya
Ugrumov, Michael V
description Abstract Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this study was to evaluate the changes in surviving nigrostriatal DA-ergic neurons with focus on tyrosine hydroxylase (TH) in MPTP-treated mice at the presymptomatic and early symptomatic stages of parkinsonism. According to our data, a partial degeneration of DA-ergic neurons at the presymptomatic stage was accompanied by: (i) no change in TH mRNA content in the substantia nigra (SN) suggesting a compensatory increase of TH gene expression in individual neurons; (ii) a decrease of TH protein content in the nigrostriatal system and no change in individual neurons, suggesting a slowdown of TH translation. When comparing DA-ergic neurons at the early symptomatic stage and presymptomatic stage, it becomes evident: (i) a decrease of TH mRNA content in the SN and hence gene expression in individual neurons; (ii) a decrease of TH content in the striatum and its increase in the SN and individual neurons suggesting an acceleration of TH translation. TH activity, an index of the rate of DA synthesis, was unchanged in the SN and decreased in the striatum to the same degree at both stages of parkinsonism. In the meantime, TH activity in individual neurons appeared to be compensatory increased, but to a higher degree at the symptomatic stage than at the presymptomatic one. These data first show that DA depletion, which provokes motor dysfunction, is not a result of the decrease of TH activity and the rate of DA synthesis but is rather related to either a decrease of DA release or an increase of DA uptake in striatal DA-ergic axons.
doi_str_mv 10.1016/j.jns.2014.03.028
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01112598v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022510X14001725</els_id><sourcerecordid>1534853135</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-3fe6af63f5c5a338aa697974ef609b4cb0b1f2d2fdd33ea68e33ad214f042c5e3</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7rj6A7yRXOpFx3w0bYogLIu6wogLjuBdyCSnM5ltk5pkhu3_8YeaOusiXohXIeF5XsJ5T1E8J3hJMKlf75d7F5cUk2qJ2RJT8aBYENGIkgvBHhYLjCktOcHfzoonMe4xxrUQ7ePijFZNLQhvF8WP9RR8tA7QbjLB3069ioDgdgwQo_UOKWeQ0skebZqQdcjZbRZSsCqpHhk_qiHbYWs1cnAI3kXkO_Tpen1dpgAqgUGD1YBUQmkHaM6dhjH5QaWszOl_3mNSW_iVMKpwY130zsbhafGoU32EZ3fnefH1_bv15VW5-vzh4-XFqtS8IqlkHdSqq1nHNVeMCaXqtmmbCroat5tKb_CGdNTQzhjGQNUCGFOGkqrDFdUc2Hnx6pS7U70cgx1UmKRXVl5drOT8hgkhlLfiSDL78sSOwX8_QExysFFD3ysH_hAl4awSnBHG_wOlhFHR8Caj5ITqPOQYoLv_BsFy7lzuZe5czp1LzGTuPDsv7uIPmwHMvfG75Ay8OQGQZ3e0EGTUFpwGYwPoJI23_4x_-5ete-usVv0NTBD3_hBcLkUSGanE8su8dPPOkQpj0lDOfgLEi9Xw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521328757</pqid></control><display><type>article</type><title>Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kozina, Elena A ; Khakimova, Gulnara R ; Khaindrava, Vitaly G ; Kucheryanu, Valeriayn G ; Vorobyeva, Nadezhda E ; Krasnov, Alexey N ; Georgieva, Sophia G ; Kerkerian-Le Goff, Lidiya ; Ugrumov, Michael V</creator><creatorcontrib>Kozina, Elena A ; Khakimova, Gulnara R ; Khaindrava, Vitaly G ; Kucheryanu, Valeriayn G ; Vorobyeva, Nadezhda E ; Krasnov, Alexey N ; Georgieva, Sophia G ; Kerkerian-Le Goff, Lidiya ; Ugrumov, Michael V</creatorcontrib><description>Abstract Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this study was to evaluate the changes in surviving nigrostriatal DA-ergic neurons with focus on tyrosine hydroxylase (TH) in MPTP-treated mice at the presymptomatic and early symptomatic stages of parkinsonism. According to our data, a partial degeneration of DA-ergic neurons at the presymptomatic stage was accompanied by: (i) no change in TH mRNA content in the substantia nigra (SN) suggesting a compensatory increase of TH gene expression in individual neurons; (ii) a decrease of TH protein content in the nigrostriatal system and no change in individual neurons, suggesting a slowdown of TH translation. When comparing DA-ergic neurons at the early symptomatic stage and presymptomatic stage, it becomes evident: (i) a decrease of TH mRNA content in the SN and hence gene expression in individual neurons; (ii) a decrease of TH content in the striatum and its increase in the SN and individual neurons suggesting an acceleration of TH translation. TH activity, an index of the rate of DA synthesis, was unchanged in the SN and decreased in the striatum to the same degree at both stages of parkinsonism. In the meantime, TH activity in individual neurons appeared to be compensatory increased, but to a higher degree at the symptomatic stage than at the presymptomatic one. These data first show that DA depletion, which provokes motor dysfunction, is not a result of the decrease of TH activity and the rate of DA synthesis but is rather related to either a decrease of DA release or an increase of DA uptake in striatal DA-ergic axons.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/j.jns.2014.03.028</identifier><identifier>PMID: 24768159</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ; Animals ; Aromatic Amino Acid Decarboxylase Inhibitors - pharmacology ; Cellular Biology ; Corpus Striatum - pathology ; Disease Models, Animal ; Dopamine ; Dopamine - metabolism ; Dopaminergic Neurons - physiology ; Electrochemistry ; Gene Expression Regulation - drug effects ; Hydrazines - pharmacology ; Levodopa - metabolism ; Life Sciences ; Male ; Mice ; Mice, Inbred C57BL ; Motor Activity - drug effects ; Motor Activity - physiology ; MPTP Poisoning - pathology ; MPTP Poisoning - physiopathology ; Neurology ; Nigrostriatal system ; Parkinson's disease ; RNA, Messenger - metabolism ; Substantia Nigra - pathology ; Tyrosine 3-Monooxygenase - genetics ; Tyrosine 3-Monooxygenase - metabolism ; Tyrosine hydroxylase</subject><ispartof>Journal of the neurological sciences, 2014-05, Vol.340 (1), p.198-207</ispartof><rights>Elsevier B.V.</rights><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-3fe6af63f5c5a338aa697974ef609b4cb0b1f2d2fdd33ea68e33ad214f042c5e3</citedby><cites>FETCH-LOGICAL-c541t-3fe6af63f5c5a338aa697974ef609b4cb0b1f2d2fdd33ea68e33ad214f042c5e3</cites><orcidid>0000-0002-7951-3479</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022510X14001725$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24768159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01112598$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kozina, Elena A</creatorcontrib><creatorcontrib>Khakimova, Gulnara R</creatorcontrib><creatorcontrib>Khaindrava, Vitaly G</creatorcontrib><creatorcontrib>Kucheryanu, Valeriayn G</creatorcontrib><creatorcontrib>Vorobyeva, Nadezhda E</creatorcontrib><creatorcontrib>Krasnov, Alexey N</creatorcontrib><creatorcontrib>Georgieva, Sophia G</creatorcontrib><creatorcontrib>Kerkerian-Le Goff, Lidiya</creatorcontrib><creatorcontrib>Ugrumov, Michael V</creatorcontrib><title>Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Abstract Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this study was to evaluate the changes in surviving nigrostriatal DA-ergic neurons with focus on tyrosine hydroxylase (TH) in MPTP-treated mice at the presymptomatic and early symptomatic stages of parkinsonism. According to our data, a partial degeneration of DA-ergic neurons at the presymptomatic stage was accompanied by: (i) no change in TH mRNA content in the substantia nigra (SN) suggesting a compensatory increase of TH gene expression in individual neurons; (ii) a decrease of TH protein content in the nigrostriatal system and no change in individual neurons, suggesting a slowdown of TH translation. When comparing DA-ergic neurons at the early symptomatic stage and presymptomatic stage, it becomes evident: (i) a decrease of TH mRNA content in the SN and hence gene expression in individual neurons; (ii) a decrease of TH content in the striatum and its increase in the SN and individual neurons suggesting an acceleration of TH translation. TH activity, an index of the rate of DA synthesis, was unchanged in the SN and decreased in the striatum to the same degree at both stages of parkinsonism. In the meantime, TH activity in individual neurons appeared to be compensatory increased, but to a higher degree at the symptomatic stage than at the presymptomatic one. These data first show that DA depletion, which provokes motor dysfunction, is not a result of the decrease of TH activity and the rate of DA synthesis but is rather related to either a decrease of DA release or an increase of DA uptake in striatal DA-ergic axons.</description><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</subject><subject>Animals</subject><subject>Aromatic Amino Acid Decarboxylase Inhibitors - pharmacology</subject><subject>Cellular Biology</subject><subject>Corpus Striatum - pathology</subject><subject>Disease Models, Animal</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Dopaminergic Neurons - physiology</subject><subject>Electrochemistry</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hydrazines - pharmacology</subject><subject>Levodopa - metabolism</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>MPTP Poisoning - pathology</subject><subject>MPTP Poisoning - physiopathology</subject><subject>Neurology</subject><subject>Nigrostriatal system</subject><subject>Parkinson's disease</subject><subject>RNA, Messenger - metabolism</subject><subject>Substantia Nigra - pathology</subject><subject>Tyrosine 3-Monooxygenase - genetics</subject><subject>Tyrosine 3-Monooxygenase - metabolism</subject><subject>Tyrosine hydroxylase</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkl2L1DAUhoso7rj6A7yRXOpFx3w0bYogLIu6wogLjuBdyCSnM5ltk5pkhu3_8YeaOusiXohXIeF5XsJ5T1E8J3hJMKlf75d7F5cUk2qJ2RJT8aBYENGIkgvBHhYLjCktOcHfzoonMe4xxrUQ7ePijFZNLQhvF8WP9RR8tA7QbjLB3069ioDgdgwQo_UOKWeQ0skebZqQdcjZbRZSsCqpHhk_qiHbYWs1cnAI3kXkO_Tpen1dpgAqgUGD1YBUQmkHaM6dhjH5QaWszOl_3mNSW_iVMKpwY130zsbhafGoU32EZ3fnefH1_bv15VW5-vzh4-XFqtS8IqlkHdSqq1nHNVeMCaXqtmmbCroat5tKb_CGdNTQzhjGQNUCGFOGkqrDFdUc2Hnx6pS7U70cgx1UmKRXVl5drOT8hgkhlLfiSDL78sSOwX8_QExysFFD3ysH_hAl4awSnBHG_wOlhFHR8Caj5ITqPOQYoLv_BsFy7lzuZe5czp1LzGTuPDsv7uIPmwHMvfG75Ay8OQGQZ3e0EGTUFpwGYwPoJI23_4x_-5ete-usVv0NTBD3_hBcLkUSGanE8su8dPPOkQpj0lDOfgLEi9Xw</recordid><startdate>20140515</startdate><enddate>20140515</enddate><creator>Kozina, Elena A</creator><creator>Khakimova, Gulnara R</creator><creator>Khaindrava, Vitaly G</creator><creator>Kucheryanu, Valeriayn G</creator><creator>Vorobyeva, Nadezhda E</creator><creator>Krasnov, Alexey N</creator><creator>Georgieva, Sophia G</creator><creator>Kerkerian-Le Goff, Lidiya</creator><creator>Ugrumov, Michael V</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7951-3479</orcidid></search><sort><creationdate>20140515</creationdate><title>Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism</title><author>Kozina, Elena A ; Khakimova, Gulnara R ; Khaindrava, Vitaly G ; Kucheryanu, Valeriayn G ; Vorobyeva, Nadezhda E ; Krasnov, Alexey N ; Georgieva, Sophia G ; Kerkerian-Le Goff, Lidiya ; Ugrumov, Michael V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-3fe6af63f5c5a338aa697974ef609b4cb0b1f2d2fdd33ea68e33ad214f042c5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</topic><topic>Animals</topic><topic>Aromatic Amino Acid Decarboxylase Inhibitors - pharmacology</topic><topic>Cellular Biology</topic><topic>Corpus Striatum - pathology</topic><topic>Disease Models, Animal</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Dopaminergic Neurons - physiology</topic><topic>Electrochemistry</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hydrazines - pharmacology</topic><topic>Levodopa - metabolism</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>MPTP Poisoning - pathology</topic><topic>MPTP Poisoning - physiopathology</topic><topic>Neurology</topic><topic>Nigrostriatal system</topic><topic>Parkinson's disease</topic><topic>RNA, Messenger - metabolism</topic><topic>Substantia Nigra - pathology</topic><topic>Tyrosine 3-Monooxygenase - genetics</topic><topic>Tyrosine 3-Monooxygenase - metabolism</topic><topic>Tyrosine hydroxylase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kozina, Elena A</creatorcontrib><creatorcontrib>Khakimova, Gulnara R</creatorcontrib><creatorcontrib>Khaindrava, Vitaly G</creatorcontrib><creatorcontrib>Kucheryanu, Valeriayn G</creatorcontrib><creatorcontrib>Vorobyeva, Nadezhda E</creatorcontrib><creatorcontrib>Krasnov, Alexey N</creatorcontrib><creatorcontrib>Georgieva, Sophia G</creatorcontrib><creatorcontrib>Kerkerian-Le Goff, Lidiya</creatorcontrib><creatorcontrib>Ugrumov, Michael V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kozina, Elena A</au><au>Khakimova, Gulnara R</au><au>Khaindrava, Vitaly G</au><au>Kucheryanu, Valeriayn G</au><au>Vorobyeva, Nadezhda E</au><au>Krasnov, Alexey N</au><au>Georgieva, Sophia G</au><au>Kerkerian-Le Goff, Lidiya</au><au>Ugrumov, Michael V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>2014-05-15</date><risdate>2014</risdate><volume>340</volume><issue>1</issue><spage>198</spage><epage>207</epage><pages>198-207</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><abstract>Abstract Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this study was to evaluate the changes in surviving nigrostriatal DA-ergic neurons with focus on tyrosine hydroxylase (TH) in MPTP-treated mice at the presymptomatic and early symptomatic stages of parkinsonism. According to our data, a partial degeneration of DA-ergic neurons at the presymptomatic stage was accompanied by: (i) no change in TH mRNA content in the substantia nigra (SN) suggesting a compensatory increase of TH gene expression in individual neurons; (ii) a decrease of TH protein content in the nigrostriatal system and no change in individual neurons, suggesting a slowdown of TH translation. When comparing DA-ergic neurons at the early symptomatic stage and presymptomatic stage, it becomes evident: (i) a decrease of TH mRNA content in the SN and hence gene expression in individual neurons; (ii) a decrease of TH content in the striatum and its increase in the SN and individual neurons suggesting an acceleration of TH translation. TH activity, an index of the rate of DA synthesis, was unchanged in the SN and decreased in the striatum to the same degree at both stages of parkinsonism. In the meantime, TH activity in individual neurons appeared to be compensatory increased, but to a higher degree at the symptomatic stage than at the presymptomatic one. These data first show that DA depletion, which provokes motor dysfunction, is not a result of the decrease of TH activity and the rate of DA synthesis but is rather related to either a decrease of DA release or an increase of DA uptake in striatal DA-ergic axons.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>24768159</pmid><doi>10.1016/j.jns.2014.03.028</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7951-3479</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 2014-05, Vol.340 (1), p.198-207
issn 0022-510X
1878-5883
language eng
recordid cdi_hal_primary_oai_HAL_hal_01112598v1
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Aromatic Amino Acid Decarboxylase Inhibitors - pharmacology
Cellular Biology
Corpus Striatum - pathology
Disease Models, Animal
Dopamine
Dopamine - metabolism
Dopaminergic Neurons - physiology
Electrochemistry
Gene Expression Regulation - drug effects
Hydrazines - pharmacology
Levodopa - metabolism
Life Sciences
Male
Mice
Mice, Inbred C57BL
Motor Activity - drug effects
Motor Activity - physiology
MPTP Poisoning - pathology
MPTP Poisoning - physiopathology
Neurology
Nigrostriatal system
Parkinson's disease
RNA, Messenger - metabolism
Substantia Nigra - pathology
Tyrosine 3-Monooxygenase - genetics
Tyrosine 3-Monooxygenase - metabolism
Tyrosine hydroxylase
title Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A37%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tyrosine%20hydroxylase%20expression%20and%20activity%20in%20nigrostriatal%20dopaminergic%20neurons%20of%20MPTP-treated%20mice%20at%20the%20presymptomatic%20and%20symptomatic%20stages%20of%20parkinsonism&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Kozina,%20Elena%20A&rft.date=2014-05-15&rft.volume=340&rft.issue=1&rft.spage=198&rft.epage=207&rft.pages=198-207&rft.issn=0022-510X&rft.eissn=1878-5883&rft_id=info:doi/10.1016/j.jns.2014.03.028&rft_dat=%3Cproquest_hal_p%3E1534853135%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521328757&rft_id=info:pmid/24768159&rft_els_id=1_s2_0_S0022510X14001725&rfr_iscdi=true